
The presence of major American executives alongside President Donald Trump during high-level China engagements reveals a critical transformation in global power: multinational corporations are no longer merely economic actors. They are geopolitical participants. Executives from companies including Apple, Tesla, BlackRock, Qualcomm, and Boeing understand that the future global economy will be shaped not simply by markets, but by strategic negotiations between states, supply chains, artificial intelligence, semiconductors, and industrial dependency.
Historically, diplomacy belonged primarily to nation-states. Today, corporations often possess resources, data infrastructures, technological influence, and supply-chain leverage exceeding those of many governments. Technology companies control communication systems. Financial institutions shape capital flows. Semiconductor firms influence national security capabilities.
China understands this reality deeply. American corporations continue depending heavily on Chinese manufacturing capacity, consumer markets, rare earth processing, battery infrastructure, and industrial ecosystems. Simultaneously, the United States increasingly views Chinese technological advancement as a national security challenge.
Executives accompanying political delegations therefore serve dual purposes: commercial negotiation and strategic signalling. Their presence demonstrates that despite political tensions, economic interdependence remains extraordinarily deep.

For years, political rhetoric in Washington promoted the idea of economic “decoupling” from China. Yet global supply chains remain deeply integrated. Apple’s manufacturing dependencies, Tesla’s Shanghai operations, semiconductor production chains, and rare-earth mineral processing networks reveal how difficult true separation would be.
The modern economy was built around efficiency, not geopolitical resilience. Corporations optimised for cost reduction, just-in-time logistics, and global integration. The result is a system where geopolitical rivalry coexists alongside profound economic dependence.
This contradiction creates structural instability. Governments seek strategic autonomy while corporations seek market continuity. CEOs increasingly find themselves balancing shareholder expectations against national security concerns.

Unlike the ideological Cold War between the United States and Soviet Union, the emerging U.S.-China rivalry is economically intertwined. The battlefield is no longer solely military positioning. It includes semiconductors, AI leadership, cloud computing, electric vehicles, shipping corridors, pharmaceuticals, quantum research, and energy infrastructure.
Executives participating in diplomatic visits are therefore not merely business leaders. They are intermediaries inside a larger contest over technological and economic supremacy.
This convergence of politics and commerce also raises uncomfortable questions about democratic accountability. As corporations accumulate geopolitical influence, who ultimately shapes national priorities — elected governments or multinational capital systems?

The future global order will not be determined solely in parliaments or military headquarters. It will increasingly be negotiated inside boardrooms, semiconductor facilities, cloud infrastructures, logistics networks, and AI laboratories. The CEOs travelling to China are not tourists. They are participants in the redesign of the 21st-century power structure. The deeper issue is no longer whether business and politics intersect. It is whether modern democracies still possess the capacity to separate them at all.

For most of aviation history, human flight has required an aircraft: a machine large enough to generate lift, carry fuel, accommodate passengers, and surround its occupants with an engineered structure. Emerging personal-flight technologies are beginning to loosen that relationship. Jet suits, powered wings, compact electric vertical-lift systems, autonomous drones, and increasingly sophisticated flight-control technologies suggest that aviation may eventually encompass machines worn, mounted, or summoned rather than conventionally boarded. The viral spectacle is irresistible. A person rises from the ground, accelerates over water, and appears to have acquired a superpower. Yet spectacle obscures the engineering. Human-scale powered flight confronts brutal constraints involving energy density, heat, noise, stability, endurance, payload, weather, redundancy, training, regulation, and the consequences of mechanical failure. A technology can fly successfully and still be unsuitable for mass transportation. That distinction is central to understanding personal aviation. The most plausible near-term applications are unlikely to involve commuters casually flying between homes and offices. Specialist environments — emergency response, defence, offshore infrastructure, inaccessible terrain, inspection, rescue, and certain industrial operations — provide a more credible pathway because the economic value of reaching somewhere quickly can outweigh the technology’s considerable limitations. The deeper development, however, extends beyond jet suits. Aviation is becoming computational. Sensors can stabilise machines faster than human reflexes. Software can continuously adjust thrust. Lightweight materials reduce mass. Autonomous navigation increasingly separates piloting from constant manual control. Electric propulsion enables aircraft configurations that would have been impractical under traditional mechanical architectures. The result is not necessarily the death of the aeroplane. Commercial aircraft remain extraordinarily efficient at moving large numbers of people over long distances. Instead, aviation may be fragmenting into a richer ecosystem: aircraft for distance, drones for autonomous logistics, eVTOL systems for specialised regional movement, and wearable or highly compact systems for particular human-scale missions. The important question is therefore no longer simply, “Can a person fly without an aeroplane?” We already know that certain machines can make that possible. The better question is: when does removing the aircraft make flight more useful?

Canada’s Medical Assistance in Dying programme has moved an ancient human question into modern medicine: when suffering becomes intolerable, who should have authority over how life ends? In 2024, 16,499 people received MAID—5.1 per cent of deaths in Canada. Yet the headline conceals crucial distinctions: 95.6 per cent were people whose natural deaths were reasonably foreseeable; 4.4 per cent were not. Most recipients had received palliative care, while disability advocates, clinicians, ethicists and policymakers continue to dispute whether safeguards can adequately separate autonomous choice from suffering intensified by inadequate social support. The future makes the question harder. Medicine is simultaneously extending life, managing once-fatal disease, expanding organ transplantation and developing technologies that could prolong healthy longevity. A civilisation capable of keeping people alive for longer must therefore become equally sophisticated about what makes continued life worth living. The central question is larger than MAID: can a society protect the right to choose death without allowing failures of care to narrow the possibility of choosing life?

For four decades, the central challenge of HIV medicine has been control. Antiretroviral therapy can suppress the virus so effectively that people living with HIV can lead long, healthy lives and, when viral load remains undetectable, do not transmit HIV sexually. Yet treatment does not remove the latent viral reservoir embedded within the body, meaning therapy usually must continue. A developing body of HIV research is asking a different question: rather than continually suppressing an active virus, could medicine make its hidden genetic machinery remain silent? A 2025 Science Advances study found that an HIV-derived antisense transcript known as AST could reinforce viral latency in cells from people receiving treatment. Subsequent research confirmed that HIV antisense transcripts occur naturally in people living with the virus. These findings do not constitute an HIV cure. They reveal something potentially more consequential: another biological mechanism that scientists may eventually learn to manipulate. The larger intelligence is about where medicine may be heading—from repeatedly controlling disease towards redesigning the conditions that allow disease to persist.